Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.

Decousser JW, Woerther PL, Soussy CJ, Fines-Guyon M, Dowzicky MJ.

Antimicrob Resist Infect Control. 2018 May 30;7:68. doi: 10.1186/s13756-018-0360-y. eCollection 2018.

2.

Distribution and antimicrobial susceptibility of bacteria from adults with community-acquired pneumonia or complicated skin and soft tissue infections in France: the nationwide French PREMIUM study.

Leprince C, Desroches M, Emirian A, Coutureau C, Anais L, Fihman V, Soussy CJ, Decousser JW; PREMIUM study group.

Diagn Microbiol Infect Dis. 2015 Oct;83(2):175-82. doi: 10.1016/j.diagmicrobio.2015.06.007. Epub 2015 Jun 17.

3.

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.

Mouton JW, Brown DF, Apfalter P, Cantón R, Giske CG, Ivanova M, MacGowan AP, Rodloff A, Soussy CJ, Steinbakk M, Kahlmeter G.

Clin Microbiol Infect. 2012 Mar;18(3):E37-45. doi: 10.1111/j.1469-0691.2011.03752.x. Epub 2012 Jan 20. Review.

4.

EUCAST expert rules in antimicrobial susceptibility testing.

Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G.

Clin Microbiol Infect. 2013 Feb;19(2):141-60. doi: 10.1111/j.1469-0691.2011.03703.x. Epub 2011 Nov 25. Review.

5.

Bacterial hypermutation: clinical implications.

Jolivet-Gougeon A, Kovacs B, Le Gall-David S, Le Bars H, Bousarghin L, Bonnaure-Mallet M, Lobel B, Guillé F, Soussy CJ, Tenke P.

J Med Microbiol. 2011 May;60(Pt 5):563-73. doi: 10.1099/jmm.0.024083-0. Epub 2011 Feb 24. Review.

PMID:
21349992
6.

In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Muller-Serieys C, Drugeon HB, Kitzis MD, Reverdy ME, Roussel-Delvallez M, Moubareck C, Brémont S, Miara A, Gjoklaj M, Soussy CJ.

Int J Antimicrob Agents. 2011 Mar;37(3):235-9. doi: 10.1016/j.ijantimicag.2010.11.035. Epub 2011 Feb 4.

7.

In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Armand-Lefevre L, Drugeon HB, Kitzis MD, Muller-Serieys C, Reverdy ME, Roussel-Delvallez M, Moubareck C, Lemire A, Miara A, Gjoklaj M, Soussy CJ.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):475-82. doi: 10.1007/s10096-010-1117-6. Epub 2010 Nov 19. Review.

8.

[Activity of doripenem against anaerobic bacteria].

Dubreuil L, Neut C, Mahieux S, Muller-Serieys C, Jean-Pierre H, Marchandin H, Soussy CJ, Miara A.

Pathol Biol (Paris). 2011 Apr;59(2):102-7. doi: 10.1016/j.patbio.2010.03.006. Epub 2010 May 26. French.

PMID:
20537808
9.

Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.

Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B; Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France.

Arch Intern Med. 2010 Mar 22;170(6):552-9. doi: 10.1001/archinternmed.2010.32.

PMID:
20308642
10.

[Diagnosis and treatment of acute uncomplicated urethritis of men: guidelines from the French committee of infectious disease of the French association of urology (CIAFU)].

Cariou G, Sotto A, Bugel H, Escaravage L, Mignard JP, Hoznek A, Bernard L, Boiteux JP, Thibault M, Soussy CJ, Coloby P, Bruyère F; French association of urology (CIAFU).

Prog Urol. 2010 Mar;20(3):184-7. doi: 10.1016/j.purol.2009.11.002. French.

PMID:
20230939
11.

[Recommendations of the Infectious Disease Committee of the French Association of Urology (AFU): antibiotic prophylaxis for urological procedures].

Bruyère F, Sotto A, Escaravage L, Cariou G, Mignard JP, Coloby P, Hoznek A, Bernard L, Boiteux JP, Thibault M, Soussy CJ, Bugel H; Infectious Disease Committee of the French Association of Urology (AFU).

Prog Urol. 2010 Feb;20(2):101-8. doi: 10.1016/j.purol.2009.11.003. Epub 2009 Dec 14. French.

PMID:
20142050
12.

Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.

Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Deforges L, Soussy CJ, Delchier JC, Megraud F.

J Clin Microbiol. 2009 Nov;47(11):3600-7. doi: 10.1128/JCM.00744-09. Epub 2009 Sep 16.

13.

The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex.

Mérens A, Matrat S, Aubry A, Lascols C, Jarlier V, Soussy CJ, Cavallo JD, Cambau E.

J Bacteriol. 2009 Mar;191(5):1587-94. doi: 10.1128/JB.01205-08. Epub 2008 Dec 5.

14.

[European requirements in microbiological evaluation of antibiotics].

Soussy CJ.

Med Mal Infect. 2008 Dec;38(12):623-4. doi: 10.1016/j.medmal.2008.09.023. Epub 2008 Nov 7. French. No abstract available.

PMID:
18995975
15.

First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.

Liassine N, Zulueta-Rodriguez P, Corbel C, Lascols C, Soussy CJ, Cambau E.

J Antimicrob Chemother. 2008 Nov;62(5):1151-2. doi: 10.1093/jac/dkn295. Epub 2008 Jul 31. No abstract available.

PMID:
18669519
16.

Self-reported childhood trauma correlates with schizotypal measures in schizophrenia but not bipolar pedigrees.

Schürhoff F, Laguerre A, Fisher H, Etain B, Méary A, Soussy C, Szöke A, Leboyer M.

Psychol Med. 2009 Mar;39(3):365-70. doi: 10.1017/S0033291708003905. Epub 2008 Jun 30.

17.

[Acute prostatitis].

Bruyère F, Cariou G, Boiteux JP, Hoznek A, Mignard JP, Escaravage L, Bernard L, Sotto A, Soussy CJ, Coloby P; le CIAFU.

Prog Urol. 2008 Mar;18 Suppl 1:19-23. doi: 10.1016/S1166-7087(08)70508-6. Review. French.

PMID:
18455078
18.

[Acute pyelonephritis].

Bruyère F, Cariou G, Boiteux JP, Hoznek A, Mignard JP, Escaravage L, Bernard L, Sotto A, Soussy CJ, Coloby P; le CIAFU.

Prog Urol. 2008 Mar;18 Suppl 1:14-8. doi: 10.1016/S1166-7087(08)70507-4. Review. French.

PMID:
18455077
19.

[Acute cystitis].

Bruyère F, Cariou G, Boiteux JP, Hoznek A, Mignard JP, Escaravage L, Bernard L, Sotto A, Soussy CJ, Coloby P; le CIAFU.

Prog Urol. 2008 Mar;18 Suppl 1:9-13. doi: 10.1016/S1166-7087(08)70506-2. Review. French.

PMID:
18455076
20.

[Diagnosis, treatment and follow-up of community-acquired bacterial infections of the urinary system of men and women (acute cystitis and acute pyelonephritis) and of the genital system of men (acute prostatitis): general remarks].

Bruyère F, Cariou G, Boiteux JP, Hoznek A, Mignard JP, Escaravage L, Bernard L, Sotto A, Soussy CJ, Coloby P; le CIAFU.

Prog Urol. 2008 Mar;18 Suppl 1:4-8. doi: 10.1016/S1166-7087(08)70505-0. Review. French.

PMID:
18455075
21.

[Diagnosis, treatment and follow-up of community-acquired bacterial infections of the urinary system of men and women (acute cystitis and acute pyelonephritis) and of the genital system of men (acute prostatitis): methodology].

Bruyère F, Cariou G, Boiteux JP, Hoznek A, Mignard JP, Escaravage L, Bernard L, Sotto A, Soussy CJ, Coloby P; le CIAFU.

Prog Urol. 2008 Mar;18 Suppl 1:1-3. doi: 10.1016/S1166-7087(08)70504-9. French. No abstract available.

PMID:
18455074
22.

A plasmid-borne Shewanella algae Gene, qnrA3, and its possible transfer in vivo between Kluyvera ascorbata and Klebsiella pneumoniae.

Lascols C, Podglajen I, Verdet C, Gautier V, Gutmann L, Soussy CJ, Collatz E, Cambau E.

J Bacteriol. 2008 Aug;190(15):5217-23. doi: 10.1128/JB.00243-08. Epub 2008 May 30.

23.

Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.

Cesaro A, Bettoni RR, Lascols C, Mérens A, Soussy CJ, Cambau E.

J Antimicrob Chemother. 2008 May;61(5):1007-15. doi: 10.1093/jac/dkn077. Epub 2008 Mar 6.

PMID:
18325893
24.

Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp.

Cattoir V, Poirel L, Aubert C, Soussy CJ, Nordmann P.

Emerg Infect Dis. 2008 Feb;14(2):231-7. doi: 10.3201/eid1402.070677.

25.

Routine use of real-time PCR for detection of Helicobacter pylori and of clarithromycin resistance mutations.

Tankovic J, Chaumette-Planckaert MT, Deforges L, Launay N, Le Glaunec JM, Soussy CJ, Delchier JC.

Gastroenterol Clin Biol. 2007 Oct;31(10):792-5.

26.

[In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005].

Soussy CJ, Lascols C, Dib-Smahi C; et le Groupe d'étude multicentrique.

Med Mal Infect. 2007 Nov;37(11):773-5. Epub 2007 Oct 23. French.

PMID:
17936533
27.

Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates.

Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P.

J Antimicrob Chemother. 2007 Aug;60(2):394-7. Epub 2007 Jun 8.

PMID:
17561500
28.

Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants.

Cattoir V, Poirel L, Mazel D, Soussy CJ, Nordmann P.

Antimicrob Agents Chemother. 2007 Jul;51(7):2650-1. Epub 2007 Apr 23. No abstract available.

29.

Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia.

Cattoir V, Merabet L, Legrand P, Soussy CJ, Leclercq R.

J Antimicrob Chemother. 2007 May;59(5):1010-2. Epub 2007 Apr 13.

PMID:
17434877
30.

Prevalence of qnr genes in Salmonella in France.

Cattoir V, Weill FX, Poirel L, Fabre L, Soussy CJ, Nordmann P.

J Antimicrob Chemother. 2007 Apr;59(4):751-4. Epub 2007 Feb 16.

PMID:
17307773
31.

Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.

Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E.

Int J Antimicrob Agents. 2007 Apr;29(4):389-96. Epub 2007 Feb 15.

PMID:
17303392
32.

Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.

Lascols C, Robert J, Cattoir V, Bébéar C, Cavallo JD, Podglajen I, Ploy MC, Bonnet R, Soussy CJ, Cambau E.

Int J Antimicrob Agents. 2007 Apr;29(4):402-9. Epub 2007 Jan 23.

PMID:
17254753
33.

Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.

Poirel L, Cattoir V, Soares A, Soussy CJ, Nordmann P.

Antimicrob Agents Chemother. 2007 Feb;51(2):631-7. Epub 2006 Nov 20.

35.

In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.

Cattoir V, Lesprit P, Lascols C, Denamur E, Legrand P, Soussy CJ, Cambau E.

J Antimicrob Chemother. 2006 Nov;58(5):1054-7. Epub 2006 Sep 19.

PMID:
16984897
36.

[Management of urinary tract infections in women. Epidemiologic survey of 7916 women in general practice].

Haab F, Costa P, Colau JC, Gérard A, Liard F, Bohbot JM, Leng JJ, Lobel B, Soussy CJ, Boulanger P.

Presse Med. 2006 Sep;35(9 Pt 1):1235-40. French.

PMID:
16969311
37.

Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005.

Cambau E, Lascols C, Sougakoff W, Bébéar C, Bonnet R, Cavallo JD, Gutmann L, Ploy MC, Jarlier V, Soussy CJ, Robert J.

Clin Microbiol Infect. 2006 Oct;12(10):1013-20.

38.

Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.

Dupeyron C, Campillo B, Richardet JP, Soussy CJ.

J Hosp Infect. 2006 Aug;63(4):385-92. Epub 2006 Jun 12.

PMID:
16772100
39.

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Odenholt I, Rodloff A, Soussy CJ, Steinbakk M, Soriano F, Stetsiouk O.

Clin Microbiol Infect. 2006 Jun;12(6):501-3.

40.

[Investigation of the new QNR-based mechanism of quinolone resistance among enterobacterial strains isolated in Henri-Mondor hospital 2002-2005].

Honoré S, Lascols C, Malin D, Targaouchi R, Cattoir V, Legrand P, Soussy CJ, Cambau E.

Pathol Biol (Paris). 2006 May;54(5):270-9. Epub 2006 Feb 13. French.

PMID:
16473479
41.

Blood neutrophil bactericidal activity against methicillin-resistant and methicillin-sensitive Staphylococcus aureus during cardiac surgery.

Mekontso-Dessap A, Honoré S, Kirsch M, Plonquet A, Fernandez E, Touqui L, Farcet JP, Soussy CJ, Loisance D, Delclaux C.

Shock. 2005 Aug;24(2):109-13.

PMID:
16044079
42.

Beneficial effect of an inhibitor of leukocyte elastase (EPI-hNE-4) in presence of repeated lung injuries.

Honoré S, Attalah HL, Azoulay E, Soussy CJ, Saudubray F, Harf A, Brochard L, Delclaux C.

Shock. 2004 Aug;22(2):131-6.

PMID:
15257085
43.

Decreased exhaled nitric oxide as a marker of postinsult immune paralysis.

Attalah HL, Honoré S, Eddahibi S, Marcos E, Soussy CJ, Adnot S, Delclaux C.

J Appl Physiol (1985). 2004 Oct;97(4):1188-94. Epub 2004 May 7.

44.

Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods.

Muller-Serieys C, Drugeon HB, Etienne J, Lascols C, Leclercq R, Nguyen J, Soussy CJ.

Clin Microbiol Infect. 2004 Mar;10(3):242-6.

45.

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.

Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ.

Antimicrob Agents Chemother. 2003 Dec;47(12):3942-4.

46.

In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.

Soussy CJ, Nguyen J, Goldstein F, Dabernat H, Andremont A, Leclercq R, Drugeon H, Cavallo P, Chardon H, Etienne J, Rio Y, Courvalin P.

Clin Microbiol Infect. 2003 Oct;9(10):997-1005.

47.

Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR.

Lascols C, Lamarque D, Costa JM, Copie-Bergman C, Le Glaunec JM, Deforges L, Soussy CJ, Petit JC, Delchier JC, Tankovic J.

J Clin Microbiol. 2003 Oct;41(10):4573-7.

48.

[In vitro activity of the pristinamycin against the isolated staphylococci in the french hospitals in 1999-2000].

Leclercq R, Soussy CJ, Weber P, Moniot-Ville N, Dib C; Groupe d'Etude Multicentrique.

Pathol Biol (Paris). 2003 Sep;51(7):400-4. French.

PMID:
12948760
49.

Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation.

Yang K, Azoulay E, Attalah L, Zahar JR, Van de Louw A, Cerf C, Soussy CJ, Duvaldestin P, Brochard L, Brun-Buisson C, Harf A, Delclaux C.

Intensive Care Med. 2003 Mar;29(3):396-402. Epub 2003 Jan 23.

PMID:
12541157
50.

Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats.

Attalah HL, Azoulay E, Yang K, Lasclos C, Jouault H, Soussy CJ, Guillot T, Brochard L, Brun-Buisson C, Harf A, Delclaux C.

Crit Care Med. 2002 Sep;30(9):2107-14.

PMID:
12352049

Supplemental Content

Loading ...
Support Center